Bafna Pharmaceuticals Ltd
NSE: BAFNAPH BSE: 532989
₹105.11
(-4.44%)
Fri, 13 Mar 2026, 01:15 am
Market Cap2.52B
PE Ratio25.74
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KBafna Pharmaceuticals Income Statement
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 203.58M | 360.08M | 395.16M | 457.76M | 743.84M | 1.01B | 1.25B | 1.75B | 1.85B | 1.01B | 852.86M | 649.59M | 455.62M | 436.27M | 424.73M | 712.18M | 851.40M | 1.15B | 1.52B | 1.46B |
| Gross profit | 3.76M | 4.61M | 16.51M | 56.14M | 76.19M | 118.88M | 152.02M | 233.66M | 261.13M | -76.92M | 13.39M | -32.14M | -94.73M | -35.16M | 19.29M | 89.83M | 137.18M | 175.56M | 215.36M | 168.77M |
| Operating expenses (excl. COGS) | 0 | 0 | -2.35M | -25.43M | -21.15M | -31.84M | -54.42M | -88.33M | -100.31M | -114.88M | -49.50M | -65.86M | -289.92M | -129.19M | -39.12M | -31.29M | -72.20M | -71.63M | -151.85M | -103.35M |
| Selling/general/admin expenses, total | — | — | — | -23.88M | -20.76M | -31.81M | -54.38M | -87.54M | -99.14M | -92.87M | -38.15M | -62.46M | -290.62M | -127.14M | -38.65M | -31.29M | -72.14M | -66.55M | -141.53M | -86.31M |
| Research & development | — | — | — | — | — | — | — | — | — | — | -8.17M | -7.18M | -3.71M | -7.53M | -10.10M | -13.59M | -14.73M | -15.21M | -15.36M | -21.94M |
| Selling/general/admin expenses, other | — | — | — | -23.88M | -20.76M | -31.81M | -54.38M | -87.54M | -99.14M | -92.87M | -29.98M | -55.28M | -286.91M | -119.61M | -28.56M | -17.70M | -72.14M | -51.34M | -126.16M | -64.36M |
| Other operating expenses, total | 0 | 0 | -2.35M | -1.55M | -392.43K | -32.43K | -43.02K | -792.20K | -1.18M | -22.01M | -11.35M | -3.39M | 698.00K | -2.05M | -463.00K | 0 | -58.00K | -5.08M | -10.33M | -17.04M |
| Operating income | 3.76M | 4.61M | 14.16M | 30.71M | 55.04M | 87.04M | 97.59M | 145.33M | 160.82M | -191.80M | -36.11M | -98.00M | -384.64M | -164.34M | -19.82M | 58.55M | 64.98M | 103.92M | 63.51M | 65.42M |
| Non-operating income, total | 6.84M | 7.30M | -1.29M | -6.08M | -15.39M | -36.80M | -43.88M | -90.41M | -135.90M | 252.47M | -117.08M | -105.63M | 237.48M | -18.58M | 1.04M | -279.00K | -12.82M | 12.24M | 9.97M | -23.89M |
| Interest expense, net of interest capitalized | -4.99M | -5.08M | -4.40M | -18.73M | -19.05M | -36.37M | -72.28M | -107.75M | -132.14M | -134.61M | -129.56M | -114.74M | -69.43M | -21.27M | -955.00K | -7.42M | -7.94M | -20.38M | -22.90M | -27.31M |
| Interest capitalized | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 11.83M | 12.38M | 3.11M | 12.65M | 3.66M | -431.77K | 29.72M | 16.57M | -2.87M | 417.21M | 12.77M | 11.38M | 309.51M | 2.69M | 2.00M | 7.14M | 16.57M | 31.09M | 33.04M | 22.55M |
| Non-operating interest income | 386.00K | 104.00K | 492.12K | 6.29M | 1.96M | 3.21M | 3.24M | 3.93M | 3.60M | 3.69M | 3.88M | 1.85M | 285.00K | 2.50M | 394.00K | 395.00K | 336.00K | 445.00K | 1.25M | 1.36M |
| Miscellaneous non-operating expense | 11.45M | 12.28M | 2.62M | 6.36M | 1.70M | -3.64M | 26.48M | 12.64M | -6.48M | 413.53M | 6.76M | 9.53M | 309.23M | 188.00K | 1.60M | 6.75M | 15.58M | 29.65M | 30.74M | 19.85M |
| Unusual income/expense | — | — | — | — | — | — | -1.32M | 777.84K | -893.72K | -30.13M | -293.47K | -2.28M | -2.60M | -5.00K | 0 | 0 | -21.45M | 1.53M | -164.00K | -19.13M |
| Pretax income | 10.60M | 11.91M | 12.87M | 24.62M | 39.65M | 50.24M | 53.71M | 54.92M | 24.91M | 60.67M | -153.19M | -203.63M | -147.17M | -182.93M | -18.78M | 58.27M | 52.16M | 116.16M | 73.48M | 41.52M |
| Taxes | -1.37M | -1.49M | -887.36K | -13.95M | -14.84M | -16.76M | -34.66M | -14.79M | -10.47M | 1.53M | 1.78M | 9.03M | -21.93M | -10.67M | 0 | 0 | 0 | -2.78M | 0 | 0 |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | -647.19K | -504.75K | -408.14K | -423.68K | 11.14M | 3.73M | 1.73M | -5.20M | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 9.23M | 10.42M | 11.98M | 10.68M | 24.81M | 33.48M | 18.41M | 39.63M | 14.04M | 61.77M | -140.27M | -190.87M | -167.37M | -198.80M | -18.78M | 58.27M | 52.16M | 113.38M | 73.48M | 41.52M |
| Net income | 9.23M | 10.42M | 11.98M | 10.68M | 24.81M | 33.48M | 18.41M | 39.63M | 14.04M | 61.77M | -140.27M | -190.87M | -167.37M | -198.80M | -18.78M | 58.27M | 52.16M | 113.38M | 73.48M | 41.52M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 9.23M | 10.42M | 11.98M | 10.68M | 24.81M | 33.48M | 18.41M | 39.63M | 14.04M | 61.77M | -140.27M | -190.87M | -167.37M | -198.80M | -18.78M | 58.27M | 52.16M | 113.38M | 73.48M | 41.52M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 6.43M | 8.29M | 17.77M | 49.61M | 77.60M | 114.73M | 160.62M | 227.82M | 250.75M | -131.95M | 12.47M | -55.80M | -344.90M | -129.58M | 12.84M | 103.33M | 119.92M | 157.27M | 113.46M | 114.31M |
| EBIT | 3.76M | 4.61M | 14.16M | 30.71M | 55.04M | 87.04M | 97.59M | 145.33M | 160.82M | -191.80M | -36.11M | -98.00M | -384.64M | -164.34M | -19.82M | 58.55M | 64.98M | 103.92M | 63.51M | 65.42M |
| Total operating expenses | -199.81M | -355.48M | -381.00M | -427.05M | -688.80M | -925.98M | -1.16B | -1.61B | -1.69B | -1.20B | -888.97M | -747.59M | -840.26M | -600.61M | -444.55M | -653.63M | -786.42M | -1.05B | -1.46B | -1.39B |
| Prepaid expenses | 9.83M | 524.00K | 958.92K | 1.85M | 323.40K | 727.26K | 1.81M | 2.65M | 2.64M | 1.60M | 39.67M | 726.00K | 88.00K | 795.00K | 1.28M | 2.34M | 2.75M | 3.73M | 4.61M | 5.21M |
| Deferred income, current | — | — | — | — | — | — | — | — | 11.27M | 86.48M | 81.36M | 90.63M | 24.53M | 12.54M | 25.10M | 8.92M | 0 | 400.00K | 1.63M | 8.40M |
| Capital and operating lease obligations | — | — | 0 | 0 | 0 | 652.56K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 1.09M | 1.30M | 1.16M | 12.28M | 22.08M | 28.18M | 52.50M | 58.34M | 64.11M | 39.99M | 38.22M | 29.19M | 51.11M | 61.79M | — | — | — | — | — | — |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 8.00M | 8.51M | 8.92M | 9.34M | 0 | -5.54M | -7.26M | -2.06M | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | — | -13.02M | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800